Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily Living.

Goubault E, Nguyen HP, Bogard S, Blanchet PJ, Bézard E, Vincent C, Sarna J, Monchi O, Duval C.

Front Neurol. 2019 Mar 22;10:256. doi: 10.3389/fneur.2019.00256. eCollection 2019.

2.

Parkinson's disease patients experiencing peak-dose dyskinesia redistribute involuntary movements throughout their body to improve motor control.

Lebel K, Duval C, Goubault E, Bogard S, Blanchet PJ.

Parkinsonism Relat Disord. 2019 Mar 23. pii: S1353-8020(19)30109-9. doi: 10.1016/j.parkreldis.2019.03.016. [Epub ahead of print]

3.

Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates.

Hernandez G, Mahmoudi S, Cyr M, Diaz J, Blanchet PJ, Lévesque D.

Mov Disord. 2019 May;34(5):717-726. doi: 10.1002/mds.27630. Epub 2019 Jan 24.

PMID:
30675935
4.

Electrophysiological predictors of cognitive-behavioral therapy outcome in tic disorders.

Morand-Beaulieu S, O'Connor KP, Blanchet PJ, Lavoie ME.

J Psychiatr Res. 2018 Oct;105:113-122. doi: 10.1016/j.jpsychires.2018.08.020. Epub 2018 Sep 4.

PMID:
30219560
5.

Preparation and characterisation of flame retardant encapsulated with functionalised silica-based shell.

Hoang DT, Schorr D, Landry V, Blanchet P, Vanslambrouck S, Dagenais C.

J Microencapsul. 2018 Aug;35(5):428-438. doi: 10.1080/02652048.2018.1521477. Epub 2018 Oct 23.

PMID:
30189763
6.

Cardinal Motor Features of Parkinson's Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia.

Goubault E, Nguyen HP, Bogard S, Blanchet PJ, Bézard E, Vincent C, Langlois M, Duval C.

J Parkinsons Dis. 2018;8(2):323-331. doi: 10.3233/JPD-181312.

7.

Chronic pain and pain processing in Parkinson's disease.

Blanchet PJ, Brefel-Courbon C.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):200-206. doi: 10.1016/j.pnpbp.2017.10.010. Epub 2017 Oct 12. Review.

PMID:
29031913
8.

Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs.

Lévesque C, Hernandez G, Mahmoudi S, Calon F, Gasparini F, Gomez-Mancilla B, Blanchet PJ, Lévesque D.

Neuroscience. 2017 Oct 11;361:43-57. doi: 10.1016/j.neuroscience.2017.07.068. Epub 2017 Aug 5.

PMID:
28790021
9.

P300 Source Localization Contrasts in Body-Focused Repetitive Behaviors and Tic Disorders.

Sauvé G, Morand-Beaulieu S, O'Connor KP, Blanchet PJ, Lavoie ME.

Brain Sci. 2017 Jul 1;7(7). pii: E76. doi: 10.3390/brainsci7070076.

10.

Characterization of Burning Mouth Syndrome in Patients with Parkinson's Disease.

Bonenfant D, Rompré PH, Rei N, Jodoin N, Soland VL, Rey V, Brefel-Courbon C, Ory-Magne F, Rascol O, Blanchet PJ.

J Oral Facial Pain Headache. 2016 Fall;30(4):318-322. doi: 10.11607/ofph.1691.

PMID:
27792799
11.

The Impact of a Cognitive-Behavioral Therapy on Event-Related Potentials in Patients with Tic Disorders or Body-Focused Repetitive Behaviors.

Morand-Beaulieu S, O'Connor KP, Richard M, Sauvé G, Leclerc JB, Blanchet PJ, Lavoie ME.

Front Psychiatry. 2016 May 10;7:81. doi: 10.3389/fpsyt.2016.00081. eCollection 2016.

12.

Wood degradation under UV irradiation: A lignin characterization.

Cogulet A, Blanchet P, Landry V.

J Photochem Photobiol B. 2016 May;158:184-91. doi: 10.1016/j.jphotobiol.2016.02.030. Epub 2016 Mar 6.

PMID:
26974579
13.

Evaluation of a cognitive psychophysiological model for management of tic disorders: an open trial.

O'Connor K, Lavoie M, Blanchet P, St-Pierre-Delorme MÈ.

Br J Psychiatry. 2016 Jul;209(1):76-83. doi: 10.1192/bjp.bp.114.154518. Epub 2015 Aug 6.

PMID:
26250742
14.

In memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014.

Blanchet PJ, Pourcher E.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 3;60:132-3. Review. No abstract available.

PMID:
26153581
15.

Impact of Parkinson's disease on proprioceptively based on-line movement control.

Mongeon D, Blanchet P, Bergeron S, Messier J.

Exp Brain Res. 2015 Sep;233(9):2707-21. doi: 10.1007/s00221-015-4343-4. Epub 2015 Jun 9.

PMID:
26055990
16.

Cognitive-behavioral therapy induces sensorimotor and specific electrocortical changes in chronic tic and Tourette's disorder.

Morand-Beaulieu S, O'Connor KP, Sauvé G, Blanchet PJ, Lavoie ME.

Neuropsychologia. 2015 Dec;79(Pt B):310-21. doi: 10.1016/j.neuropsychologia.2015.05.024. Epub 2015 May 27.

PMID:
26022060
17.

In memoriam: Paul J. Bedard, MD PhD (1942-2014).

Di Paolo T, Blanchet PJ.

Parkinsonism Relat Disord. 2015 May;21(5):429. doi: 10.1016/j.parkreldis.2015.01.014. Epub 2015 Jan 31. No abstract available.

PMID:
25737206
18.

In memoriam: Paul J. Bédard, MD PhD: January 19, 1942-December 26, 2014.

Blanchet PJ, Pourcher E.

Mov Disord. 2015 Mar;30(3):299-300. doi: 10.1002/mds.26186. Epub 2015 Feb 20. No abstract available.

PMID:
25702916
19.

Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.

Mahmoudi S, Lévesque D, Blanchet PJ.

Mov Disord. 2014 Aug;29(9):1125-33. doi: 10.1002/mds.25909. Epub 2014 May 16.

20.

New and emerging treatments for symptomatic tardive dyskinesia.

Rana AQ, Chaudry ZM, Blanchet PJ.

Drug Des Devel Ther. 2013 Nov 6;7:1329-40. doi: 10.2147/DDDT.S32328. eCollection 2013. Review.

Supplemental Content

Loading ...
Support Center